Insider Transactions in Q4 2025 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2025
|
Jeffrey M Leiden Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.0%
|
$91
$91.05 P/Share
|
|
Dec 03
2025
|
Charles F Wagner Jr EVP, CO & FO |
SELL
Open market or private sale
|
Direct |
14,000
-14.59%
|
$6,384,000
$456.0 P/Share
|
|
Dec 03
2025
|
Jeffrey M Leiden Executive Chairman |
SELL
Open market or private sale
|
Direct |
63,781
-9.71%
|
$28,510,107
$447.7 P/Share
|
|
Dec 03
2025
|
Jeffrey M Leiden Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
63,781
+42.08%
|
$5,485,166
$86.52 P/Share
|
|
Dec 03
2025
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
4,500
-8.77%
|
$2,020,500
$449.99 P/Share
|
|
Dec 03
2025
|
Jonathan Biller EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
347
-2.22%
|
$155,803
$449.0 P/Share
|
|
Nov 19
2025
|
Lloyd Carney Director |
SELL
Bona fide gift
|
Direct |
800
-11.24%
|
-
|
|
Nov 17
2025
|
Edward Morrow Atkinson Iii EVP, Chief Technical Ops. Off. |
SELL
Open market or private sale
|
Direct |
2,500
-12.92%
|
$1,085,000
$434.58 P/Share
|
|
Nov 14
2025
|
Jeffrey M Leiden Executive Chairman |
SELL
Open market or private sale
|
Direct |
53,604
-29.56%
|
$23,639,364
$441.22 P/Share
|
|
Nov 14
2025
|
Jeffrey M Leiden Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
53,604
+30.32%
|
$4,717,152
$88.79 P/Share
|
|
Nov 13
2025
|
Jeffrey M Leiden Executive Chairman |
SELL
Open market or private sale
|
Direct |
19,688
-23.5%
|
$8,662,720
$440.63 P/Share
|
|
Nov 13
2025
|
Jeffrey M Leiden Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
19,688
+31.05%
|
$1,791,608
$91.05 P/Share
|
|
Oct 02
2025
|
Jonathan Biller EVP and Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
694
-4.25%
|
$280,376
$404.21 P/Share
|
|
Oct 01
2025
|
Jonathan Biller EVP and Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,259
-7.15%
|
$503,600
$400.0 P/Share
|